| Yehuda E Salamon, MD | |
|
7590 Auburn Rd, Painesville, OH 44077-9176 | |
| (440) 350-0832 | |
| (440) 579-0191 |
| Full Name | Yehuda E Salamon |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 7590 Auburn Rd, Painesville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447599485 | NPI | - | NPPES |
| 0338791 | Medicaid | OH | |
| H663450 | Other | OH | MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 35.134291 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lake Health | Concord, OH | Hospital |
| Lake Health Beachwood Medical Center | Beachwood, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Primary Care Practices Inc | 3072417534 | 940 |
News Archive
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.
EDGE Medical Devices today announced that it has received the 2010 North American Enabling Technology Award in Digital Radiography (DR) from global research and consulting firm Frost & Sullivan. The award was given in recognition of EDGE's Plasma DR™ readout technology, which is used in its flat-panel detector and Universal Retrofit Kit. The technology enables EDGE to deliver both cost and performance advantages over traditional digital radiography flat-panel detectors.
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
› Verified 9 days ago
| Entity Name | University Primary Care Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003935339 PECOS PAC ID: 3072417534 Enrollment ID: O20031125000767 |
News Archive
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.
EDGE Medical Devices today announced that it has received the 2010 North American Enabling Technology Award in Digital Radiography (DR) from global research and consulting firm Frost & Sullivan. The award was given in recognition of EDGE's Plasma DR™ readout technology, which is used in its flat-panel detector and Universal Retrofit Kit. The technology enables EDGE to deliver both cost and performance advantages over traditional digital radiography flat-panel detectors.
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
› Verified 9 days ago
| Entity Name | Anesthesia Associates Pll |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801823182 PECOS PAC ID: 5395648679 Enrollment ID: O20040202000866 |
News Archive
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.
EDGE Medical Devices today announced that it has received the 2010 North American Enabling Technology Award in Digital Radiography (DR) from global research and consulting firm Frost & Sullivan. The award was given in recognition of EDGE's Plasma DR™ readout technology, which is used in its flat-panel detector and Universal Retrofit Kit. The technology enables EDGE to deliver both cost and performance advantages over traditional digital radiography flat-panel detectors.
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
› Verified 9 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.
EDGE Medical Devices today announced that it has received the 2010 North American Enabling Technology Award in Digital Radiography (DR) from global research and consulting firm Frost & Sullivan. The award was given in recognition of EDGE's Plasma DR™ readout technology, which is used in its flat-panel detector and Universal Retrofit Kit. The technology enables EDGE to deliver both cost and performance advantages over traditional digital radiography flat-panel detectors.
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
› Verified 9 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.
EDGE Medical Devices today announced that it has received the 2010 North American Enabling Technology Award in Digital Radiography (DR) from global research and consulting firm Frost & Sullivan. The award was given in recognition of EDGE's Plasma DR™ readout technology, which is used in its flat-panel detector and Universal Retrofit Kit. The technology enables EDGE to deliver both cost and performance advantages over traditional digital radiography flat-panel detectors.
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yehuda E Salamon, MD 7757 Auburn Rd Ste 15, Painesville, OH 44077-9604 Ph: (440) 350-0832 | Yehuda E Salamon, MD 7590 Auburn Rd, Painesville, OH 44077-9176 Ph: (440) 350-0832 |
News Archive
MedAssurant, Inc., a leading provider of data-driven healthcare solutions, announced today that the Disease Management Purchasing Consortium (DMPC) has certified the event rate outcomes for HIP Health Plan of New York (HIP) Medicare Advantage patients.
A clinical trial conducted at UNC Lineberger Comprehensive Cancer Center and Johns Hopkins Sidney Kimmel Comprehensive Cancer Center found that high-dose cytarabine followed by subsequent immunotherapy treatment with pembrolizumab benefited patients with resistant or relapsed acute myeloid leukemia (AML), a highly aggressive cancer.
EDGE Medical Devices today announced that it has received the 2010 North American Enabling Technology Award in Digital Radiography (DR) from global research and consulting firm Frost & Sullivan. The award was given in recognition of EDGE's Plasma DR™ readout technology, which is used in its flat-panel detector and Universal Retrofit Kit. The technology enables EDGE to deliver both cost and performance advantages over traditional digital radiography flat-panel detectors.
Women 65 or older who have even mild retinopathy, a disease of blood vessels in the retina, are more likely to have cognitive decline and related vascular changes in the brain, according to a multi-institutional study led by scientists at the University of California, San Francisco (UCSF).
› Verified 9 days ago
Dr. Donnah W Whitaker, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7757 Auburn Rd Ste 15, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-354-7420 | |
Dr. John R Hagopian, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7590 Auburn Rd, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-579-0191 | |
Dr. Young Lee, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-354-7420 | |
Dr. John Joseph Scerbo, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7590 Auburn Rd, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-579-0191 | |
Dr. Christine Jordan, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-354-7420 | |
Dr. William E Cress, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 40 W Erie St, Suite 203, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-354-7420 | |
Dr. Paul Anders Bjorn, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7590 Auburn Rd, Painesville, OH 44077 Phone: 440-350-0832 Fax: 440-579-0191 |